Showing results (241-250 of 325) with videos related to
Sort By:
Pageof 33
Global Health & Medicine|May 5, 2025
Large-scale screening of SARS-CoV-2 variants in Tokyo, Japan: A 3-year and 9-month longitudinal surveyJunko S Takeuchi, Kei Yamamoto, Masami Kurokawa, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profilesRena Nishizawa, Toshihiko Nishiyama, Katsuya Hisaichi, et al.Organic & Biomolecular Chemistry|July 8, 2024
Design of substituted tetrahydrofuran derivatives for HIV-1 protease inhibitors: synthesis, biological evaluation, and X-ray structural studiesArun K Ghosh, Daniel Lee, Ashish Sharma, et al.Journal of Medicinal Chemistry|September 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl MoietiesKohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.Blood|July 20, 2002
Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitroShoichi Nagakura, Sonoko Ishihara, Daniel E Dunn, et al.ACS Medicinal Chemistry Letters|October 16, 2020
Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors with P2-Carboxamide FunctionalitiesArun K Ghosh, Alessandro Grillo, Jakka Raghavaiah, et al.Journal of Medicinal Chemistry|July 11, 2003
A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitudeYongseok Choi, Clifford George, Maria J Comin, et al.BMC Infectious Diseases|May 4, 2023
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, et al.Life (Basel, Switzerland)|November 25, 2023
Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered IndividualsMari Terada, Sho Saito, Satoshi Kutsuna, et al.The Journal of Organic Chemistry|March 25, 2016
Diastereoselective Synthesis of 6″-(Z)- and 6″-(E)-Fluoro Analogues of Anti-hepatitis B Virus Agent Entecavir and Its Evaluation of the Activity and Toxicity Profile of the DiastereomersHiroki Kumamoto, Misato Fukano, Tomohiko Nakano, et al.Pageof 33